QRM Tools for Contract Biomanufacturing
Quality-risk management tools can assist biopharma companies in mitigating risks when outsourcing crucial elements of the drug-development process.
Fill/Finish Trends
Automation and disposables continue to reduce human error.
Biopharma Advances Demand Specialized Expertise
Contract service providers share insights on biopharma market developments and the implications of biosimilar drug approvals.
Protecting Intellectual Property in Engagements with CMOs
Important IP contractual provisions should be included when working with CMOs.
Taking a “Development-by-Design” Approach to Cell Therapies
Whether outsourcing or developing cell therapies in-house, success demands a focus on quality, cost of goods, and sustainability from the start.
